68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)

Clinical trial NCT06852820 · RECRUITING

Trial details

NCT number: NCT06852820
Sponsor: Melissa Lumish
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Cancer Hepatocellular Carcinoma Metastatic Liver Cancer

Start date: 2026-06-01
Primary completion: 2026-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.